R&D Systems Inc. Tocris Bioscience Boston Biochem

MRS 2179 tetrasodium salt

Cat. No. 0900

MRS 2179 tetrasodium salt C11H13N5O9P2Na4 [101204-49-3]

Price and Availability

For MRS 2179 tetrasodium salt pricing & availability please select your country from the drop down menu:
Submit
By clicking submit you agree to accept a cookie from Tocris Bioscience. For details, please read our privacy and cookie policy.

Chemical Name: 2'-Deoxy-N6-methyladenosine 3',5'-bisphosphate tetrasodium salt

Biological Activity

A competitive antagonist at P2Y1 receptors (KB = 100 nM). Selective over P2X1 (IC50 = 1.15 μM), P2X3 (IC50 = 12.9 μM), P2X2, P2X4, P2Y2, P2Y4 and P2Y6 receptors. Inhibits the upregulation of NTPDase1 by ATPγS.

Licensing Information

Sold under license from the NIH, US Patent 60/029,855

Technical Data

M.Wt:
513.16
Formula:
C11H13N5O9P2Na4
Solubility:
Soluble to 100 mM in water
Purity:
>98 %
Storage:
Desiccate at -20°C
CAS No:
101204-49-3

The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.

Certificate of Analysis / Safety Data Sheet

Certificate of Analysis: View current batch
Select another batch:
Safety Data Sheet: View Safety Data Sheet

References

Boyer et al (1998) Competitive and selective antagonism of P2Y1 receptors by N6-methyl 2'-deoxyadenosine 3',5'-bisphosphate. Br.J.Pharmacol. 124 1. PMID: 9630335.

Brown et al (2000) Activity of novel adenine nucleotide derivatives as agonists and antagonists at recombinant rat P2X receptors. Drug Dev.Res. 49 253.

Nandanan et al (2000) Synthesis, biological activity, and molecular modeling of ribose-modified deoxyadenosine bisphosphate analogues as P2Y1 receptor ligands. J.Med.Chem. 43 829. PMID: 10715151.

Lu et al (2007) Stimulation of the P2Y1 receptor up-regulates nucleoside-triphosphate diphosphohydrolase-1 in human retinal pigment epithelial cells. J.Pharmacol.Exp.Ther. 323 157. PMID: 17626796.

If you know of a relevant citation for this product please let us know.

View Related Products by Target

Keywords: MRS 2179 tetrasodium salt, supplier, Selective, P2Y1, antagonists, Receptors, Purinergic, purinoceptors, MRS2179, tetrasodium, salt

Quick Order

Find multiple products by catalog number

divider line

Cardiovascular Guide

Request your free copy

Cardiovascular Research Guide

Highlights over 250 products for cardiovascular research. Request a copy or view PDF today.

divider line

P2 Receptors Review

Purinergic Receptor Review

Written by Kenneth Jacobson, an expert in the field. Request a copy or view PDF today.

divider line

Regulation of Vascular Reactivity by GPCRs

Written by J.J. Maguire and A.P. Davenport

Cardiovascular Poster

'Regulation of Vascular Reactivity by G-protein-coupled Receptors' summarizes the key GPCRs regulating vascular reactivity.

divider line

7-TM Receptor Signaling

Written by T. Kenakin et al

7-TM Poster

'Seven Transmembrane Receptor Signaling' highlights the multiple behaviors of 7-TMs including G-protein-dependent and -independent signaling as well as the concept of collateral efficacy

divider line

New Product Guide

NPG

Highlights over 130 new products added in 2012. Request a copy or view PDF today.

divider line

New Products in this Area

CYM 50308

Potent and selective S1P4 agonist

H2L5186303

Potent and selective LPA2 receptor antagonist

MEDICA 16

FFA1 (GPR40) agonist. Also inhibits ATP citrate lyase

BX 471

Potent, selective CCR1 antagonist

PF 04418948

Potent and selective EP2 receptor antagonist

Latanoprost

FP prostaglandin receptor agonist; also exhibits agonist activity at EP1 and EP3 receptors

GRI 977143

Selective LPA2 receptor non-lipid agonist

CYM 50260

Potent and selective S1P4 agonist

G-36

Selective GPR30 antagonist

Strontium chloride

Calcium sensing receptor (CaSR) agonist

CS 2100

Selective S1P1 agonist

SMANT hydrochloride

Inhibits Smoothened (Smo) accumulation

TUG 891

Potent and selective GPR120 agonist

IT1t dihydrochloride

Potent CXCR4 antagonist

RuBi GABA trimethylphosphine

Caged GABA; inhibits neural activity

Sign-up for new product e-alerts
divider line

20% Discount*

Potent, selective LRRK2 inhibitor

Potent LRRK2 inhibitor now available from Tocris Bioscience

Tocris is the first to launch GSK2578215A, licensed from GlaxoSmithKline, for the study of Parkinson's Disease.

* Terms & conditions